Phase II Trial of Interferon Alpha-2b plus Cisplatin and 5-FU in Recurrent or Metastatic Head and Neck Cancer

Abstracts/Posters/Presentations:

• Arquette MA, Mortimer JE, Loehrer PJ, Mandanas RA. A Phase II Hoosier Oncology Group Trial of interferon Alpha-2b (IFN) added to Cisplatin (CDDP) and 5-Fluorouracil (FU) in Recurrent or Metastatic Head and Neck Cancer: A Hoosier Oncology Group and Walther Cancer Institute Trial: HN90-1. Accepted to the ASCO Annual Meeting, May 14th – 17th, 1994, Dallas, TX